A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD

Clinical trial NCT02986321 · COMPLETED

Trial details

NCT number

NCT02986321

Sponsor

Chiesi Farmaceutici S.p.A.

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2016-12-15

Primary completion

2017-10-04

Enrollment

1130

View on ClinicalTrials.gov